Amosyt may be available in the countries listed below.
Ingredient matches for Amosyt
Dimenhydrinate is reported as an ingredient of Amosyt in the following countries:
- Sweden
International Drug Name Search
Amosyt may be available in the countries listed below.
Dimenhydrinate is reported as an ingredient of Amosyt in the following countries:
International Drug Name Search
Generic Name: onabotulinumtoxinA (Botox) (ON a BOT ue LYE num TOX in A)
Brand Names: Botox, Botox Cosmetic
OnabotulinumtoxinA (Botox), also called botulinum toxin type A, is made from the bacteria that causes botulism. Botulinum toxin blocks nerve activity in the muscles, causing a temporary reduction in muscle activity.
Botox is used to treat cervical dystonia (severe spasms in the neck muscles), muscle spasms in the arms and hands, and severe underarm sweating (hyperhidrosis).
Botox is also used to treat certain eye muscle conditions caused by nerve disorders. This includes uncontrolled blinking or spasm of the eyelids, and a condition in which the eyes do not point in the same direction.
Botox is also used to treat overactive bladder and incontinence (urine leakage) caused by nerve disorders such as spinal cord injury or multiple sclerosis.
Botox is also used to prevent chronic migraine headaches in adults who have migraines for more than 15 days per month, each lasting 4 hours or longer. Botox should not be used to treat a common tension headache.
Botox Cosmetic is used to temporarily lessen the appearance of facial wrinkles.
Botox may also be used for other purposes not listed in this medication guide.
The botulinum toxin contained in this medication can spread to other body areas beyond where it was injected. This has caused serious life-threatening side effects in some people receiving botulism toxin injections, even for cosmetic purposes.
Using this medication more often than prescribed will not make it more effective and may result in serious side effects.
Before receiving a botulinum toxin injection, tell your doctor if you have ALS ( Lou Gehrig's disease), myasthenia gravis, Lambert-Eaton syndrome, a breathing disorder, trouble swallowing, facial muscle weakness, a change in the appearance of your face, seizures, bleeding problems, heart disease, if you have had or will have surgery, or if you have ever received other botulinum toxin injections such as Dysport or Myobloc.
The effects of a botulinum toxin injection are temporary. Your symptoms may return completely within 3 months after an injection. After repeat injections, it may take less and less time before your symptoms return, especially if your body develops antibodies to the botulinum toxin.
To make sure you can safely use Botox, tell your doctor if you have any of these other conditions:
amyotrophic lateral sclerosis (ALS, or "Lou Gehrig's disease");
myasthenia gravis;
Lambert-Eaton syndrome;
a breathing disorder such as asthma or emphysema;
problems with swallowing;
facial muscle weakness (droopy eyelids, weak forehead, trouble raising your eyebrows);
a change in the normal appearance of your face;
a seizure disorder;
bleeding problems;
heart disease;
if you have had or will have surgery (especially on your face); or
if you have ever received other botulinum toxin injections such as Dysport or Myobloc (especially in the last 4 months).
Botox is made from human plasma (part of the blood) which may contain viruses and other infectious agents. Donated plasma is tested and treated to reduce the risk of it containing infectious agents, but there is still a small possibility it could transmit disease. Talk with your doctor about the risks and benefits of using this medication.
This medication is injected into a muscle. A doctor, nurse, or other healthcare provider will give you this injection. Botox injections should be spaced at least 3 months apart.
Your injection may be given into more than one area at a time, depending on the condition being treated.
While receiving botulinum toxin injections for an eye muscle conditions, you may need to use eye drops, ointment, a special contact lens or other device to protect the surface of your eye. Follow your doctor's instructions.
If you are being treated for excessive sweating, shave your underarms about 24 hours before you will receive your injection. Do not apply underarm antiperspirants or deodorants for 24 hours before you receive the injection. Avoid exercise and hot foods or beverages within 30 minutes before the injection.
It may take up to 2 weeks after injection before neck muscle spasm symptoms begin to improve. You may notice the greatest improvement at 6 weeks after injection.
It may take only 1 to 3 days after injection before eye muscle spasm symptoms begin to improve. You may notice the greatest improvement at 2 to 6 weeks after injection.
Using this medication more often than prescribed will not make it more effective and may result in serious side effects.
Since botulinum toxin has a temporary effect and is given at widely spaced intervals, missing a dose is not likely to be harmful.
Overdose symptoms may not appear right away, but can include muscle weakness, trouble swallowing, and weak or shallow breathing.
Avoid using underarm antiperspirants or deodorants for 24 hours after a botulinum toxin injection if you are being treated for excessive underarm sweating.
Avoid going back to your normal physical activities too quickly after receiving an injection.
The botulinum toxin contained in Botox can spread to other body areas beyond where it was injected. This has caused serious life-threatening side effects in some people receiving botulism toxin injections, even for cosmetic purposes.
trouble breathing, talking, or swallowing;
hoarse voice, drooping eyelids;
unusual or severe muscle weakness (especially in a body area that was not injected with the medication);
loss of bladder control;
problems with vision;
crusting or drainage from your eyes;
severe skin rash or itching;
fast, slow, or uneven heartbeats; or
chest pain or heavy feeling, pain spreading to the arm or shoulder, general ill feeling.
Less serious side effects may include:
muscle weakness near where the medicine was injected;
bruising, bleeding, pain, redness, or swelling where the injection was given;
headache, muscle stiffness, neck or back pain;
fever, cough, sore throat, runny nose, flu symptoms,
dizziness, drowsiness, tired feeling;
nausea, diarrhea, stomach pain, loss of appetite;
dry mouth, dry eyes, ringing in your ears;
increased sweating in areas other than the underarms;
itchy or watery eyes, increased sensitivity to light; or
eyelid swelling or bruising.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Tell your doctor about all other medications you use, especially:
an injected antibiotic such as amikacin (Amikin), gentamicin (Garamycin), kanamycin (Kantrex), neomycin (Mycifradin, Neo-Fradin, Neo-Tab), paromomycin (Humatin, Paromycin), streptomycin, tobramycin (Nebcin, Tobi).
This list is not complete and other drugs may interact with Botox. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
See also: Botox side effects (in more detail)
Cisaprida L.CH. may be available in the countries listed below.
Cisapride is reported as an ingredient of Cisaprida L.CH. in the following countries:
International Drug Name Search
Gammalon may be available in the countries listed below.
Aminobutyric Acid, þ- is reported as an ingredient of Gammalon in the following countries:
International Drug Name Search
Omeprazol Goibela may be available in the countries listed below.
Omeprazole is reported as an ingredient of Omeprazol Goibela in the following countries:
International Drug Name Search
Miansérine may be available in the countries listed below.
Miansérine (DCF) is also known as Mianserin (Rec.INN)
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |